Evaluating candidate autoantigens in rheumatoid arthritis

Springer Seminars in Immunopathology

Volumn 20, Issue 1-2, 1998, Pages 23-39

  Cope, Andrew P ^a   Sønderstrup, Grete ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; EPITOPE; HLA DR ANTIGEN; HLA DR4 ANTIGEN; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; DISEASE PREDISPOSITION; INSULIN DEPENDENT DIABETES MELLITUS; JOINT; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; TRANSGENIC MOUSE;

ALLELES; ANIMALS; ANTIGENS, CD4; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; CARTILAGE; DISEASE MODELS, ANIMAL; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; GENETIC PREDISPOSITION TO DISEASE; HLA-DR4 ANTIGEN; HUMANS; HYBRIDOMAS; MICE; MICE, TRANSGENIC; OSTEOCHONDRITIS;

EID: 0031756976     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00831997     Document Type: Article

References (82)

1. Castano L, Eisenbarth GS (1986) Type I diabetes: a chronic autoimmune disease of humans, mouse and rat. Annu Rev Immunol 8: 647
2. Katz JD, Benoist C, Mathis D (1995) T helper subsets in insulin dependent diabetes. Science 268: 1185
3. Liblau R, Tisch R, Bercovici N, McDevitt HO (1997) Systemic antigen in the treatment of T cell mediated autoimmune disease. Iminunol Today 18: 599
4. Nordling C, Karlsson-Parra A, Jansson L, Holmdahl R, Klareskog L (1992) Characterization of a spontaneously occurring arthritis in male DBA/1 mice. Arthritis Rheum 35: 717
5. Fugger L, Michie SA, Rulifson I, Lock CB, Sonderstrup-McDevitt G (1994) Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region β-chain T-cell repertoire and mediates an HLA-DR-restricted immune response. Proc Natl Acad Sci USA 91: 6151
6. Harris EJ (1997) Clinical features of rheumatoid arthritis. In: Kelley W, Harris E, Ruddy S, Sledge C (eds) Textbook of Rheumatology. Saumlers, Philadelphia, pp 898-932
7. Pincus T, Brooks RH, Callahan LF (1994) Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures. Ann Intern Med 120: 26
8. Silman AJ, MacGregor A, Thomson W, Holligan S, Carthy D, Ollier WER (1993) Twin concordance rates for rheumatoid arthritis: results of a nationwide study. Br J Rheumatol 32: 903
9. Deighton CM, Walker DJ, Griffiths ID, Roberts DF (1989) The contribution of HLA to rheumatoid arthritis. Clin Genet 36: 178
10. Winchester R (1994) The Molecular basis of susceptibility to rheumatoid arthritis Adv Immunol 56: 389
11. Stastny P (1978) Association of B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 298: 869
12. Gregerson PK, Silver J, Winchester RJ (1987) The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30: 1205
13. Nepom GT, Byers P, Seyfried C, Healey LA, Wilske KR, Stage D, Nepom BS (1989) HLA genes associated with rheumatoid arthritis: identification of susceptibility alleles using specific oligonucleotide probes. Arthritis Rheum 32:15
14. Wordsworth BP, Lanchbury JS, Sakkas LI, Welsh KI, Panayi GS, Bell JI (1989) HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc Natl Acad Sci USA 86: 10049
15. Brown JH, Jardetsky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC (1993) Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364: 33
16. Stern LJ, Brown JH, Jardetsky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC (1994) Crystal Structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368: 215
17. Hammer J, Gallazzi F, Bono E, Karr RW, Guenot J, Valsasnini P, Nagy ZA, Sinigaglia F (1995) Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J Exp Mcd 181: 1847
18. Fu X, Bono CP, Woulfe SL, Swearingen C, Summers NL, Sinigaglia F, Sette A, Schwartz BD, Karr RW (1995) Pocket 4 of the HLA-DR(αβ1*0401) molecule is a major determinant of T cell recognition of peptide. J Exp Med 181: 915
19. Todd JA, Acha-Orbea H, Bell JI, Chao N, Fronek Z, Jacob CO, McDermott M, Sinha AA, Timmerman L, Steinman L, McDevitt HO (1988) A molecular basis for MHC class II-associated autoimmunity. Science 240: 1003
20. Wucherpfennig KW, Strominger JL (1995) Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases. J Exp Med 181: 1597
21. Barber LD, Bal V, Lamb JR, O'Hehir RE, Yendle J, Hancock RJ, Lechler RI (1991) Contribution of T-cell receptor-contacting and peptide-binding residues of the class II molecule HLA-DR4 Dw10 to serologic and antigen-specific T-cell recognition. Hum lmmunol 32: 110
22. Walser-Kuntz DR, Weyand CM, Weaver AJ, O'Fallon WM, Goronzy JJ (1995) Mechanisms underlying the formation of the T cell receptor repertoire in rheumatoid arthritis. Immunity 2: 597
23. Dessen A, Lawrence CM, Cupo S, Zaller DM, Wiley DC (1997) X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. Immunity 7: 473
24. Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC (1996) Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384: 134
25. Garcia KC, Degano M, Stanfield RL, Brunmark A, Jackson MR, Peterson PA, Teyton L, Wilson IA (1996) An alpha-beta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science 274: 209
26. Penzotti JE, Doherty D, Lybrand TP, Nepom GT (1996) A structural model for TCR recognition of the HLA class II shared epitope sequence implicated in susceptibility to rheumatoid arthritis. J Autoimmun 9: 287
27. Weyand CM, McCarthy TG, Goronzy JJ (1995) Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest 95: 2120
28. Weyand CM, Xie CP, Goronzy JJ (1992) Homozygosity for the HLA-DRB1 allele selected for extra-articular manifestations in rheumatoid arthritis. J Clin Invest 89: 2033
29. Griffiths MM, Eichwald EJ, Martin JH, Smith CB, DeWitt CW (1981) Immunogenetic control of experimental type II collagen-induced arthritis. Arthritis Rheum 24: 781
30. Nabozny GH, Baisch JM, Cheng S, Cosgrove D, Griffiths MM, Luthra HS, David CS (1996) HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J Exp Med 183: 27
31. Cope AP, Fugger LH, Chu W, Sønderstrup-McDevitt G (1997) Collagen induced arthritis in HLA-DR4/human CD4 transgenic mice. In: Charron D (ed) Genetic diversity of HLA. Functional and medical implications. EDK, Paris, pp 634-637
32. Rosloniec EF, Brand, DD, Myers LK, Esaki Y, Whittington KB, Zaller DM, Woods A, Stuart JM, Kang AH (1998) Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen. J Immunol 160: 2573
33. Rosloniec EF, Brand DD, Myers LK, Whittington KB, Gumanovskaya M, Zaller DM, Woods A, Altmann DM, Stuart JM, Kang AH (1997) An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J Exp Med 185: 1113
34. Eden W van, Holoshitz J, Nevo Z, Frenkel A, Klajman A, Cohen IR (1985) Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci USA 82: 5117
35. Taylor PC, Plater-Zyberk C, Maini RN (1995) The role of the B cells in the adoptive transfer of collagen-induced arthritis from DBA/1 (H-2q) to SCID (H-2d) mice. Eur J Immunol 25: 763
36. Hawa M, Rowe R, Lan MS, Notkins AL, Pozzilli P, Christie MR, Leslie RD (1997) Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type I diabetes. Diabetes 46: 1270
37. Elkon KB (1998) Autoantibodies in SLE. In: Klippel JH, Dieppe PA (eds) Rheumatology. Mosby, London, section 5.1-10
38. Karopoulus C, Rowley MJ, Ilic MZ, Handley CJ (1996) Presence of antibodies to native G1 domain of aggrecan core protein in synovial fluid levels from patients with various joint diseases. Arthritis Rheum 39: 1990
39. Holmdahl R, Malmstrom V, Vuorio E (1993) Autoimmune recognition of cartilage collagens. Ann Med 25: 251
40. Mottonen T, Hannonen P, Oka M (1988) Antibodies against native collagen II do not precede the clinical onset of rheumatoid arthritis. Arthritis Rheum 31: 776
41. Smiley JD, Sachs C, Ziff M (1968). In vitro synthesis of immunoglobulin by rheumatoid synovial membrane. J Clin Invest 47: 624
42. Holmdahl R, Mo JA, Jonsson R, Karlstrom K, Scheynius A (1991) Multiple epitopes on cartilage type II collagen are accessible for antibody binding in vivo. Autoimmunity 10: 27
43. Parekh RB, Dwek RA, Sutton BJ, et al (1985) Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 316: 452
44. Schellekens GA, Jong BA de, Hoogen FH van den, Putte LB van de, Venrooij WJ van (1998) Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 101: 273
45. Londei M, Savill CM, Verhoef A, Brennan F, Leech ZA, Duance V, Maini RN, Feldmann M (1989) Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis. Proc Natl Acad Sci USA 86: 636
46. Goodacre JA, Pearson JP (1992) Human cartilage proteoglycans as T-cell autoantigens. Ann Rheum Dis 51: 1094
47. Guerassimov A, Zhang Y, Banerjee S, Cartman A, Leroux JY, Rosenberg LC, Esdaile J, Fitzcharles MA, Poole AR (1998) Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate. Arthritis Rheum 41: 1019
48. Glant TT, Buzas EI, Finnegan A, Negroiu G, Cs-Szabo G, Mikecz K (1998) Critical roles of glycosaminoglycan side chains of curtilage proteoglycan (aggrecan) in antigen recognition and presentation. J Immunol 160: 3812
49. Alsalameh S, Mollenhauer J, Hain N, Stock K-P, Kalden JK Burmester GR (1990) Cellular immune response toward human articular chondrocytes. Arthritis Rheum 33: 1477
50. Verheijden GF, Rijnders AWM, Bos E, Coenen-deRoo CJJ, van Stavern CJ, Elewaut D, De Kayser F, Veys E, Boots AMH (1997) Human cartilage glycoprotein-39 is a candidate autoantigen in rheumatoid arthritis. Arthritis Rheum 40: 1115
51. Hain NA, Stuhlmüller B, Hahn GR, Kalden JR, Deutzmann R, Burmesler GR (1996) Biochemical characterization and microsequencing of a 205-kDa synovial protein stimulatory for T cells and reactive with rheumatoid factor containing sera. J Immunol 157: 1773
52. Life PF, Bassey EOF, Gaston JSH (1991) T-cell recognition of bacterial heat shock proteins in inflammatory arthritis. Immunol Rev 121: 113
53. Scotet E, David-Ameline J, Peyrat MA, Moreau-Aubry A, Pinczon D, Lim A, Even J, Semana G, Berthelot JM, Breathnach R, Bonneville M, Houssaint E (1996) T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis. J Exp Med 184: 1791
54. Albani S, Keystone EC, Nelson JL (1995) Positive selection in autoimmunity: abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis. Nat Med 1: 448
55. Waaler E (1940) On the occurrence of a factor in human scrum activating the specific agglutination of sheep blood corpuscles. Acta Pathol Microbiol Scand 17: 172
56. Michaelsson E, Malmstrom V, Reis S, Engstrom A, Burkhardt H, Holmdahl R (1994) T cell recognition of carbohydrates on type II collagen. J Exp Med 180: 745
57. Maurice MM, Lankester AC, Bezemer AC, Geertsma MF, Tal P-P, Breedveld FC, Lier RAW van, Verweij CL (1997) Defective TCR-mediated signaling in synovial T cells in rheumatoid arthritis. J Immunol 159:2973
58. Cope AP, Liblau RS, Yang XD, Congia M, Laudanna C, Schreiber RD, Probert L, Kollias G, McDevitt HO 1997 Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J Exp Med 185: 1573
59. Babbitt BP, Allen PM, Matsueda G, Haber E, Unanue ER (1985) Binding of immunogenic peptides to Ia histocompatibility molecules. Nature 17: 359
60. Friede T, Gnau V, Jung G, Keilholz W, Stevanovic S, Rammensee HG (1996) Natural ligand motifs of closely related HLA-DR4 molecules predict features of rheumatoid arthritis associated peptides. Biochim Biophys Acta 1316: 85
61. Rammensee HG, Friede T, Stevanovic S (1995) MHC ligands and peptide motifs: first listing. Immunogenetics 4: 178
62. Moudgil KD, Sekiguchi D, Kim SY, Sercarz EE (1997). Immunodominance is independent of structural constraints. J Immunol 159: 2574
63. Sercarz EE, Lehmann PV (1993) Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 11: 729
64. Busch R, Mellins ED (1996) Developing and shedding inhibitions: how MHC class II molecules reach maturity. Curr Opin Immunol 8: 51
65. Walls C (1997) Capture and processing of exogenous antigens for presentation on MHC moecules. Ann Rev Immunol 15: 821
66. Prakken AB, Eden W van, Rijkers GT, Kuis W, Toebes EA, Graeff-Meeder ER de, Zee R van der, Zegers BJ (1996) Autoreactivity to human heat-shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis. Arthritis Rheum 39: 1826
67. Mertz AK, Ugrinovic S, Lausler R, Wu P, Grolms M, Bottcher U, Appel H, Yin Z, Schiltz E, Batsford S, Schauer-Petrowski C, Braun J, Distler A, Sieper J (1998) Characterization of the synovial T cell response Io various recombinant Yersinia antigens in Yersinia enterocolitica-triggered reactive arthritis. Heat-shock protein 60 drives a major immune response. Arthritis Rheum 41: 315
68. Elias D, Markovits D, Reshet T, Zee R van der, Cohen IR (1990) Induction and therapy of autoimmune diabetes the in non-obese diabetic (NOD/LT) mouse by a 65 kDa heal shock protein. Proc Natl Acad Sci USA 87: 1576
69. Kotzin BL, Striebich CC, Falta MT, Wang Y, Bill J (1998) Identification of pathogenic T cells in rheumatoid arthritis. Pathogenesis of rheumatoid arthritis: implications for future therapy. In: Proceedings of Keystone Symposia on Molecular and Cellular Biology. Abstract, Tamarron, p 18
70. Dybwad A, Forre O, Kjeldsen-Kragh J, Natvig JB, Sioud M (1993) Identification of new B cell epitopes in the sera of rheumatoid arthritis patients using a random nanopeptide phage library. Eur J Immunol 23: 3189
71. Hakala BE, White C, Recklies AD (1993) Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 268: 25803
72. Hu B, Trinh K, Figueira WF, Price PA (1996) Isolation and sequence of a novel human chondrocyte protein related to mammalian members of the chilinase protein family. J Biol Chem 271: 19415
73. Morrison BW, Leder P (1994) neu and ras initiate murine inflammatory tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors. Oncogene 9: 3417
74. Kouskoff V, Fehling H-J, Lemeur M, Benoist C, Mathis D (1993) A vector driving the expression of foreign cDNAs in the MHC class II positive cells of transgenic mice. J Immunol Methods 166: 287
75. Fugger L, Rothbard JB, Sønderstrup-McDevitt G (1996) The Specificity of the dominant HLA-DRB1*0401-restricted T cell response to type II collagen. Eur J Immunol 26: 928
76. Cosgrove D, Gray D, Dierich A, Kaufman J, Lemeur M, Benoit C, Mathis D (1991) Mice lacking MHC class II molecules. Cell 66: 1051
77. Killeen N, Sawada S, Littman DR (1993) Regulated expression of human CD4 rescues helper T cell development in mice lacking expression of endogenous CD4. EMBO J 12: 1547
78. Patel SD, Cope AP, Congia M, Chen TT, Kim E, Fugger L, Wherret D, Sønderstrup-McDevitt G (1997) Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 using HLA-DR(α1*0101, β1*0401) transgenic mice. Proc Natl Acad Sci USA 94: 8082
79. Gaur A, Boehme SA, Chalmers D, Crowe PD, Pahuja A, Ling N, Brocke S, Steinman L, Conlon PJ (1997) Amelioration of relapsing experimental autoimmune encephalomyelitis with altered myelin basic protein peptides involves different cellular mechanisms. J Neuroimmunol 74: 149
80. Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Bijl H, Woody JN (1994) Repealed therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis. Lancet 344: 1125
81. Keffer J, Proben L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D, Kollias G (1991) Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 10: 4025
82. Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D (1996) Organ-specific disease provoked by systemic autoimmunity. Cell 87: 811